# Impact of Amyloidosis on TAVI Patients

> **NCT03984877** · — · UNKNOWN · sponsor: **Javier López Pais** · enrollment: 320 (estimated)

## Conditions studied

- Valve Stenoses, Aortic
- Amyloidosis Cardiac

## Interventions

- **DIAGNOSTIC_TEST:** Diagnosis of amyloidosis

## Key facts

- **NCT ID:** NCT03984877
- **Lead sponsor:** Javier López Pais
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2019-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03984877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03984877, "Impact of Amyloidosis on TAVI Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03984877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*